Articles by Disease (Non-melanoma Skin Cancer)

Thrombospondins as Anti-Angiogenic Therapeutic Agents

Journal: Current Pharmaceutical Design
Volume: 9
Page: 583-588
Author(s): Bruno Vailhé and Jean-Jacques Feige

HLA Peptide-mediated Strategies for Modulation of Cellular and Humoral Immune Response in Transplantation

Journal: Current Pharmacogenomics
Volume: 1
Page: 17-36
Author(s): A. C. Papassavas

Vascular Endothelial Cell Growth Factor (VEGF), An Emerging Target for Cancer Chemotherapy

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 95-117
Author(s): S. Shinkaruk, M. Bayle, G. Lain and G. Deleris

Pharmacological Inhibition of Interleukin-8 (CXCL8) as a New Approach for the Prevention and Treatment of Several Human Diseases

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 2
Page: 67-79
Author(s): Cinzia Bizzarri, Marcello Allegretti, Rosa Di Bitondo, Maria Neve Cervellera, Francesco Colotta and Riccardo Bertini

Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy

Journal: Current Drug Targets
Volume: 4
Page: 113-121
Author(s): Joachim Drevs, Michael Medinger, Carmen Schmidt-Gersbach, Renate Weber and Clemens Unger

Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis

Journal: Current Drug Targets
Volume: 4
Page: 123-131
Author(s): C. Chandra Kumar

Suicide Gene Therapy Mediated by the Herpes Simplex Virus Thymidine Kinase Gene / Ganciclovir System: Fifteen Years of Application

Journal: Current Gene Therapy
Volume: 3
Page: 13-26
Author(s): C. Fillat, M. Carrio, A. Cascante and B. Sangro